Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Domenico, Di Marzo"'
Autor:
Luciano Mutti, Francesca Pentimalli, Marisa De Feo, Antonio Giordano, Cristiana Bellan, Enrico M. Bucci, Luca Luzzi, Paola Indovina, Simona De Summa, Eliseo Mattioli, Domenico Di Marzo, Carmelina Antonella Iannuzzi, Iris Maria Forte, Caterina Costa
Publikováno v:
Cell Death and Disease, Vol 11, Iss 9, Pp 1-15 (2020)
Cell Death & Disease
Cell Death & Disease
Malignant pleural mesothelioma (MPM) is an aggressive cancer, related to asbestos exposure, which has a dismal prognosis. MPM diagnosis is late and often challenging, suggesting the need to identify more reliable molecular biomarkers. Here, we set ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41aabc1ba91c4ca976bd86a746c5e8d0
http://link.springer.com/article/10.1038/s41419-020-02940-w
http://link.springer.com/article/10.1038/s41419-020-02940-w
Autor:
Carmelina Antonella Iannuzzi, Donatella Cirillo, Francesca Pentimalli, Daniela Barone, Antonio Giordano, Paola Indovina, Domenico Di Marzo, Iris Maria Forte, Francesca Capone
Glioblastoma (GB) is the most common and aggressive malignant tumor of the central nervous system. Despite current intensive treatment regimens, consisting of surgical resection followed by radiotherapy with concomitant and adjuvant temozolomide (TMZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d494a81881b1f52f53d76058cad53ccc
http://hdl.handle.net/11365/1129820
http://hdl.handle.net/11365/1129820
Autor:
Renza Vento, Antonio Giordano, Domenico Di Marzo, Giovanni Tesoriere, Riccardo Di Fiore, Francesca Pentimalli, Daniela Carlisi, Rosa Drago-Ferrante, Anna De Blasio, Iris Maria Forte
Publikováno v:
Journal of Cellular Physiology. 231:1832-1841
Osteosarcoma (OS), an aggressive highly invasive and metastatic bone-malignancy, shows therapy resistance and recurrence, two features that likely depend on cancer stem cells (CSCs), which hold both self-renewing and malignant potential. So, effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e5d72c32d07469a5b8bca46979fea38
https://doi.org/10.1002/jcp.25291
https://doi.org/10.1002/jcp.25291
Autor:
Adriano Angelucci, Domenico Di Marzo, Elisa Ceccherini, Silvia Schenone, Maurizio Botta, Claudio Festuccia, Antonio Giordano, Gianmarco Mastrogiovanni, Iris Maria Forte, Valentina Tomei, Paola Indovina, Francesca Pentimalli, Nadia Casini
Publikováno v:
Oncotarget
ResearcherID
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
Recent data suggest that SRC family kinases (SFKs) could represent potential therapeutic targets for rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children. Here, we assessed the effect of a recently developed selective SFK inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff6cbbf45fbc356a48dbbf976d0e17e
http://europepmc.org/articles/PMC4494948
http://europepmc.org/articles/PMC4494948
Autor:
Marina Di Domenico, Letizia Cito, Pasquale Somma, Antonella Penon, Franco Roviello, Luca Saragoni, Giovan Giacomo Giordano, Iris Maria Forte, Pietro Micheli, Daniela Barone, Eliseo Mattioli, Domenico Di Marzo, Elisa Ceccherini, Danila Penon, Antonia Feola, Antonio Giordano, Paola Indovina, Francesca Pentimalli
Publikováno v:
Journal of Cellular Physiology. 230:802-805
pRb2/p130 is a key tumor suppressor, whose oncosuppressive activity has mainly been attributed to its ability to negatively regulate cell cycle by interacting with the E2F4 and E2F5 transcription factors. Indeed, pRb2/p130 has been found altered in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c3a7853001097eae8c3244b8a83957
https://doi.org/10.1002/jcp.24805
https://doi.org/10.1002/jcp.24805
Autor:
Iris Maria Forte, Paola Indovina, Nadia Casini, Eleonora Marcelli, Domenico Di Marzo, Francesca Giorgi, Luigi Alfano, Antonio Giordano, Francesca Pentimalli
Publikováno v:
Cancer Biology & Therapy. 15:380-388
Malignant mesothelioma (MM) is a very aggressive asbestos-related neoplasm of the serous membranes, whose incidence is increasing worldwide. Although the introduction of new drug combinations, such as cisplatin plus pemetrexed/gemcitabine, has determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2b090dc9db15e2186c991f38414b6f
https://doi.org/10.4161/cbt.27623
https://doi.org/10.4161/cbt.27623
Autor:
DI FIORE, Riccardo, DRAGO FERRANTE, Rosa, Francesca Pentimalli, Domenico Di Marzo, Iris Maria Forte, CARLISI, Daniela, DE BLASIO, Anna, Giovanni Tesoriere, Antonio Giordano, VENTO, Renza
Introduction: Osteosarcoma (OS), an aggressive tumor a!ecting adolescents, shows therapy resistance and recurrence which can depend on cancer stem cells (CSCs), the source for tissue renewal and hold malignant potential; thus, OS treatment requires t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::d61a82127f1e9f40096f03dab76f8948
http://hdl.handle.net/10447/302719
http://hdl.handle.net/10447/302719
Autor:
Letizia, Cito, Paola, Indovina, Iris Maria, Forte, Francesca, Pentimalli, Domenico, Di Marzo, Pasquale, Somma, Daniela, Barone, Antonella, Penon, Danila, Penon, Elisa, Ceccherini, Pietro, Micheli, Luca, Saragoni, Marina, Di Domenico, Antonia, Feola, Franco, Roviello, Eliseo, Mattioli, Giovan Giacomo, Giordano, Antonio, Giordano
pRb2/p130 is a key tumor suppressor, whose oncosuppressive activity has mainly been attributed to its ability to negatively regulate cell cycle by interacting with the E2F4 and E2F5 transcription factors. Indeed, pRb2/p130 has been found altered in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7218f1cf7a90f9ac69c8c4854305ab28
http://hdl.handle.net/11365/995129
http://hdl.handle.net/11365/995129
Autor:
Antonio Giordano, Riccardo Di Fiore, Rosa Drago-Ferrante, Renza Vento, Domenico Di Marzo, Daniela Carlisi, Iris Maria Forte, Michela Giuliano, Antonella D'Anneo, Francesca Pentimalli, Anna De Blasio, Giovanni Tesoriere
Publikováno v:
International Journal of Oncology
Osteosarcoma (OS) is the most common type of bone cancer, with a peak incidence in the early childhood. Emerging evidence suggests that treatments targeting cancer stem cells (CSCs) within a tumor can halt cancer and improve patient survival. MicroRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0350a1345788fac5f28773d4ba308e1a
http://hdl.handle.net/10447/96171
http://hdl.handle.net/10447/96171
Autor:
Marina Accardo, Iris Maria Forte, Alfonso Fiorelli, Marina Di Domenico, Umberto di Serio, Vittorio D'Urso, Mario Santini, Antonio Giordano, Francesca Pentimalli, Domenico Di Marzo
OBJECTIVE: Povidone-iodine (PVP-I) or Betadine, owing to its antineoplastic activity, is also used as an adjuvant during intra-abdominal or intrathoracic surgery. However, the protocol of PVP-I administration has not been optimized to achieve the bes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becaa2cf92cbb8840144370085432944
http://hdl.handle.net/11591/182196
http://hdl.handle.net/11591/182196